The committee was tasked with conducting its own data analyses to address questions in its charge. The committee engaged a subcontractor, Westat, to carry out the data analyses. Per contractual requirements, the committee did not have access to the protected data provided by the Department of Defense (DoD) and relied on Westat’s analytic summaries for its deliberations and report. The Institutional Review Board of the National Academies of Sciences, Engineering, and Medicine approved the study.
The data requested through the Defense Health Agency (DHA) from the Military Health System Data Repository included patient-level encounter data, claims data, and Comprehensive Autism Care Demonstration (ACD) records data from calendar years 2018 through 2023 for individuals aged 1 to 18 with autism. For the data request, autism was defined by an F84.0 International Classification of Diseases (ICD)-10 code between 2018 and 2023 in the patient record. Administrative data from claims and electronic health records (EHRs) included approximately 300 fields selected from seven DHA and DoD datasets.
The seven datasets requested included the (1) Comprehensive Ambulatory/Provider Encounter Record (CAPER), (2) TRICARE Encounter Data–Institutional (TED-I), (3) TRICARE Encounter Data–Non-Institutional (TED-NI), (4) Standard Inpatient Data Record (SIDR),
(5) GENESIS (an EHR system with admission and demographic records), (6) Pharmacy Data Transaction Service (PDTS), and (7) the Defense Enrollment Eligibility Reporting System (DEERS). The datasets include all ambulatory and inpatient encounters, health services from the private sector, as well as medication and demographic information over the study period. Important data elements requested within these datasets include ICD-10 codes identifying autism and other relevant co-occurring health conditions and procedure codes identifying applied behavior analysis (ABA) and other relevant healthcare services. DEERS data include records for demographic variables, such as birth date, race/ethnicity, sex, sponsor rank, and residence zip code.
ACD data include assessments such as the Pervasive Developmental Disorder Behavior Inventory (PDDBI); the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3); Social Response Score (SRS); and Parenting Stress Index–Short Form (PSI-SF) as well as available subdomains within these tools.
Per the data sharing agreement, DHA created a limited dataset for Westat’s analyses. DHA removed medical record numbers, addresses, social security numbers and other specific identifiers before transferring data to Westat. DHA constructed a new identifier for Westat to link patients across datasets. Study results do not report data if sample sizes were 10 or fewer individuals.
Westat received the datasets from DHA on January 25, 2025. Following receipt and initial analyses, Westat requested additional data that DHA did not provide but were assumed to be in the DEERS and ACD datasets, such as enrollment date in TRICARE, referral date for ABA treatment, date of ACD enrollment and disenrollment, hours of prescribed ABA treatment, and total number of children enrolled in TRICARE annually from 2018 to 2023. This last data element was requested to calculate the prevalence of autism. The amended request was submitted on February 11, 2025. Westat received the enrollment date in TRICARE from DEERS and an estimate of beneficiaries enrolled in TRICARE on April 7, 2025, from DHA. The other requested data elements (e.g., date of referral to ACD) were not provided.
Extraction, preparation, cleaning, and transformation of provided datasets were necessary to eventually create the final analysis datasets. For example, the DEERS file was cleaned by removing duplicate records per patient and then normalizing values for relevant data (e.g., rank group codes were transformed into categorized ranks such as enlisted, officer, warrant officer, etc.). This process was repeated for non-DEERS files. These cleaned data were then appended onto each cohort population via the patient identifier and date and combined into an analytic dataset.
Westat closely followed committee definitions of cohort populations and relevant covariates. Researchers collaborated with the committee to iterate over definitions and criteria for data harmonization and analysis. In addition, Westat researchers and programmers iterated over implemented logic and ensured matching results and populations. Epidemiologists at Westat reviewed output and code from programmers to ensure specifications were implemented.
Several SAS scripts were created for this study and can be grouped by purpose.
Given limitations with the data and time available to conduct the analyses, the committee undertook analyses aimed at understanding similarities and differences between autistic individuals who participated in the ACD and those who did not. Participants in the ACD program were further divided into continuous (greater than six months of continuous ABA treatment) and intermittent participants (all others with receipt of some ABA treatment). Analyses compared demographics, clinical characteristics, as well as the amount of ABA received across groups.
Demographic variables were obtained through several data sources such as DEERS, TED-NI, CAPER, and GENESIS datasets. Linking these data resulted in variable information by beneficiary. In addition, recorded demographics changed over time within the same datasets. For DEERS data, if demographic data were not able to be merged by date, the closest record to the relevant date was kept. To mitigate these differences, mismatching demographics were set to missing, unknown, or other values.
Descriptive analysis compared frequencies and means of demographic characteristics among continuous participants, intermittent participants, and those not participating in the ACD. These analyses are further broken out by age group. Since ABA is only authorized through the ACD program in TRICARE, beneficiaries with at least one ABA claim were considered ACD participants.
Westat created descriptive tables comparing consistent, intermittent, and non-participants for ACD by the following demographic, military, and autistic characteristics. See Table D-1 for an example.
For demographic analyses, characteristics were defined by reported demographics in DEERS and matched to the nearest record in DEERS to
TABLE D-1 Sample Table for Demographic Characteristics Examined for Ages 0–2
| Characteristic | Continuous | Intermittent | Non-participant | p |
|---|---|---|---|---|
| N | 6,060 | 1,818 | 6,149 | |
| Sex | <0.001 | |||
|
Female |
1,488 (24.6) | 491 (27.0) | 1,770 (28.8) | |
|
Male |
4,552 (75.1) | 1,316 (72.4) | 4,352 (70.8) | |
|
Unknown |
20 (0.3) | 11 (0.6) | 27 (0.4) | |
| Race | <0.001 | |||
|
Asian |
122 (2.0) | 34 (1.9) | 66 (1.1) | |
|
Black |
461 (7.6) | 166 (9.1) | 290 (4.7) | |
|
Other |
1,849 (30.5) | 498 (27.4) | 1,378 (22.4) | |
|
Unknown 1 |
2,085 (34.4) | 705 (38.8) | 3,359 (54.6) | |
|
White |
1,543 (25.5) | 415 (22.8) | 1,056 (17.2) | |
| Ethnicity | <0.001 | |||
|
Hispanic |
447 (7.4) | 158 (8.7) | 312 (5.1) | |
|
Not Hispanic |
3,393 (56.0) | 937 (51.5) | 2,198 (35.7) | |
|
Other 1 |
196 (3.2) | 33 (1.8) | 281 (4.6) | |
|
Unknown 2 |
2,024 (33.4) | 690 (38.0) | 3,358 (54.6) | |
| Region | <0.001 | |||
|
Alaska |
37 (0.6) | 15 (0.8) | 47 (0.8) | |
|
East |
3,631 (59.9) | 999 (55.0) | 2,984 (48.5) | |
|
Overseas |
132 (2.2) | 58 (3.2) | 198 (3.2) | |
|
Unknown 3 |
273 (4.5) | 80 (4.4) | 1,103 (17.9) | |
|
West |
1,987 (32.8) | 666 (36.6) | 1,817 (29.5) | |
| Branch | <0.001 | |||
|
Air Force |
1,251 (20.6) | 316 (17.4) | 1,101 (17.9) | |
|
Army |
2,642 (43.6) | 866 (47.6) | 3,022 (49.1) | |
|
Coast Guard |
98 (1.6) | 34 (1.9) | 119 (1.9) | |
|
Marine Corps |
531 (8.8) | 173 (9.5) | 597 (9.7) | |
|
Navy |
1,497 (24.7) | 410 (22.6) | 1,281 (20.8) | |
|
Space Force |
<10 | <10 | <10 | |
|
Unknown 4 |
37 (0.6) | 15 (0.8) | 23 (0.4) | |
| Duty Status | <0.001 | |||
|
Active |
4,993 (82.4) | 1,410 (77.6) | 4,449 (72.4) | |
|
Guard Reserve |
312 (5.1) | 108 (5.9) | 765 (12.4) | |
|
Inactive |
614 (10.1) | 233 (12.8) | 851 (13.8) | |
|
Other 2 |
<10 | 12 (0.7) | 81 (1.3) | |
|
Unknown 5 |
138 (2.3) | 55 (3.0) | <10 |
| Characteristic | Continuous | Intermittent | Non-participant | p |
|---|---|---|---|---|
| Moved | <0.001 | |||
|
Yes |
320 (5.3) | 106 (5.8) | 424 (6.9) | |
|
No |
2,998 (49.5) | 551 (30.3) | 2,527 (41.1) | |
|
Missing |
2,729 (45.0) | 1,161 (63.9) | 3,176 (51.7) | |
|
Unknown 6 |
<10 | 0 (0.0) | 22 (0.4) | |
| Urbanicity | <0.001 | |||
|
0–50% Urban |
<10 | <10 | 24 (0.8) | |
|
50–75% Urban |
136 (4.2) | 32 (5.1) | 201 (7.1) | |
|
75–90% Urban |
395 (12.1) | 77 (12.2) | 379 (13.4) | |
|
90–99% Urban |
1,312 (40.3) | 264 (42.0) | 1,044 (36.9) | |
|
100% Urban |
1,412 (43.3) | 254 (40.4) | 1,180 (41.7) | |
| Baseline Composite PDDBI mean SD | 55.64 (14.97) | 59.93 (16.37) | 46.75 (11.45) | 0.003 |
an individual’s first autism ICD-10 code (F84.0). This approach was used for all variables and analyses unless otherwise specified.
Diagnostic specific covariates were derived using ICD-10 codes from TED-I, CAPER, SIDR, GENESIS, and TED-NI datasets.
Clinical analysis compared frequencies and means of clinical diagnosis or treatments between continuous participants, intermittent participants, and those not participating in the ACD. Treatments frequently received (e.g., speech, occupational therapy [OT]/physical therapy [PT]) and co-occurring conditions (e.g., intellectual disability) with autism were identified by the
committee. Receipt of at least one CPT or ICD code associated with the visit or diagnosis was considered positive (see Table D-2 for CPT/ICD codes). See Tables D-3, D-4, D-5, D-6, D-7, and D-8 for comparisons of clinical characteristics broken out by age group. These analyses were intended to help the committee discern whether continuous users of ABA have more severe autism and/or are more likely to receive other healthcare services.
Within each of the continuous and intermittent beneficiary groups, the committee produced summaries of the average number of ABA treatments received within a six-month period from first ABA claim. Tables provided to the committee displayed frequencies of characteristics across populations with different intensity levels. ABA intensity groupings (0–5 hours/week, 5–10 hours/week, 10–20 hours/week, 20+ hours/week) combined with participation status led to eight combinations for comparison. Additionally, the committee explored key demographics and clinical differences by participation status.
Hours per week were calculated by summing the number of “treatment” ABA CPT codes and their corresponding time amounts (did not include billing for assessment or caregiver training). Level III codes in 2018 have 30-minute increments, and Level I codes used in 2019 and on are recorded in 15-minute increments. A notable limitation in this situation is the possibility of rounding up to the nearest increment when treatment did not fall in an exact 15- or 30-minute time.
DHA provided Westat with an assessment dataset containing reported scores from all previously mentioned assessments—the PDDBI, Vineland-3, SRS, and PSI-SF. Much of these data prior to 2021 are missing precise dates of assessments and instead have ambiguously recorded year and quarter. The year and quarter recorded in the data reflect the period when the data were updated, not the date of assessment, and are of questionable utility where dates of services are required.
The committee chose specific subscores from PDDBI, Vineland-3, and SRS for analysis. These included the Vineland Composite, Socialization, Communication, Daily Living Skills, as well as both Maladaptive Internal and Externalizing Scores from the Vineland-3. Subscores from the PDDBI included Expressive Social Communication Abilities, Receptive/Expressive Social Communication Abilities Composite, Social Approach, Ritualisms/Resistance to Change, and Aggressiveness. For reference the committee also
TABLE D-2 Clinical Characteristic Fields
| Characteristics | Definition or categorization | ICD-10 codes | CPT codes |
|---|---|---|---|
| Clinical treatments defined by procedure codes | Services from a dietitian | R63.3, F50.82, F98.2, K59.0, K58, K21, K58.0, R10.9, K52.9, K52.2 | |
| Speech and language therapy | F80.0, F80.1, F80.2, F80.81, R48.8, F47.1, F80.4 | 92507, 92605, 92606, 92608, 92609, 92610, 92520, 92521, 92522, 92523, 92524, 92526 | |
| Physical and occupational therapy | M62.81, R26.9, R26.81, R26.8, R26.89, F82, G54.0 | 97129, 97130, 97533, 97110, 97112, 97116, 97530, 97535, 97755, 97140, 97124 | |
| ENT/audiology | H90.90, F90.0, H90.1, H90.2, H90.3, H65.2, H65.21, H65.22, H93.25, H66.90, H65.49, H65.196, H66.1, H65.23, H65.3, H93.25 | ||
| Co-occurring conditions defined by ICD-10 codes | ADHD | F90 | |
| Sleep disorder | G47 | ||
| Delayed milestones | F62.0 | ||
| Epilepsy | G40 | ||
| Feeding difficulties | R13.11, R13.12, R63.3, R63.31, R63.32 | 92526 | |
| Intellectual disability | F70, F71, F72, F73, F74, F75, F76, F77, F78, F79 | ||
| Depression | F32, F33 | ||
| Anxiety | F40.01, F41 | ||
| OCD | F42 | ||
| Other mental health conditions | F31, F34, F43, F60, F50, F51, F52 |
NOTE: ADHD = attention-deficit/hyperactivity disorder; ENT = ear, nose, and throat; ICD = International Classification of Diseases; OCD = obsessive-compulsive disorder.
TABLE D-3 Clinical Characteristics among Ages 0–2
| Characteristic | Continuous | Intermittent | Non-participant | p |
|---|---|---|---|---|
| N | 6,060 | 1,818 | 6,149 | |
| Dietitian | 1,336 (22.0) | 318 (17.5) | 1,225 (19.9) | <0.001 |
| Speech | 3,663 (60.4) | 945 (52.0) | 3,485 (56.7) | <0.001 |
| ADHD | 120 (2.0) | 47 (2.6) | 162 (2.6) | 0.044 |
| Sleep Disorder | 482 (8.0) | 117 (6.4) | 436 (7.1) | 0.049 |
| Genetic Disorder | 163 (2.7) | 42 (2.3) | 164 (2.7) | 0.656 |
| Delayed Milestone | 2,269 (37.4) | 467 (25.7) | 1,957 (31.8) | <0.001 |
| Epilepsy | 145 (2.4) | 35 (1.9) | 155 (2.5) | 0.344 |
| OT Feeding Difficulties | 909 (15.0) | 228 (12.5) | 847 (13.8) | 0.017 |
| Intellectual Disability | 28 (0.5) | <10 | 21 (0.3) | 0.166 |
| Other Mental Health | 177 (2.9) | 50 (2.8) | 194 (3.2) | 0.598 |
| PT/OT | 1,264 (20.9) | 301 (16.6) | 1,155 (18.8) | <0.001 |
| ENT/Audiology | 534 (8.8) | 118 (6.5) | 725 (11.8) | <0.001 |
| Depression | <10 | <10 | <10 | 0.371 |
| Anxiety | 50 (0.8) | <10 | 63 (1.0) | 0.138 |
| OCD | <10 | 0 (0.0) | <10 | 0.196 |
NOTES: ADHD = attention-deficit/hyperactivity disorder; ENT = ear, nose, and throat; OCD = obsessive-compusive disorder; OT = occupational therapy; PT = physical therapy.
TABLE D-4 Clinical Characteristics among Age 3
| Characteristic | Continuous | Intermittent | Non-participant | p |
|---|---|---|---|---|
| N | 4,210 | 1,328 | 5,175 | |
| Dietitian | 788 (18.7) | 205 (15.4) | 857 (16.6) | 0.004 |
| Speech | 2,320 (55.1) | 645 (48.6) | 2,642 (51.1) | <0.001 |
| ADHD | 250 (5.9) | 90 (6.8) | 407 (7.9) | 0.001 |
| Sleep Disorder | 288 (6.8) | 84 (6.3) | 393 (7.6) | 0.173 |
| Genetic Disorder | 93 (2.2) | 25 (1.9) | 107 (2.1) | 0.750 |
| Delayed Milestone | 1,330 (31.6) | 297 (22.4) | 1,265 (24.4) | <0.001 |
| Epilepsy | 90 (2.1) | 17 (1.3) | 123 (2.4) | 0.048 |
| OT Feeding Difficulties | 491 (11.7) | 138 (10.4) | 543 (10.5) | 0.155 |
| Intellectual Disability | 21 (0.5) | <10 | 39 (0.8) | 0.147 |
| Other Mental Health | 126 (3.0) | 39 (2.9) | 228 (4.4) | <0.001 |
| PT/OT | 792 (18.8) | 225 (16.9) | 869 (16.8) | 0.030 |
| ENT/Audiology | 254 (6.0) | 72 (5.4) | 428 (8.3) | <0.001 |
| Depression | <10 | <10 | <10 | 0.082 |
| Anxiety | 71 (1.7) | 20 (1.5) | 107 (2.1) | 0.242 |
| OCD | <10 | <10 | <10 | 0.701 |
NOTES: ADHD = attention-deficit/hyperactivity disorder; ENT = ear, nose, and throat; OCD = obsessive-compusive disorder; OT = occupational therapy; PT = physical therapy.
TABLE D-5 Clinical Characteristics among Age 4
| Characteristic | Continuous | Intermittent | Non-participant | p |
|---|---|---|---|---|
| N | 2,915 | 951 | 4,803 | |
| Dietitian | 503 (17.3) | 149 (15.7) | 706 (14.7) | 0.011 |
| Speech | 1,440 (49.4) | 418 (44.0) | 2,118 (44.1) | <0.001 |
| ADHD | 400 (13.7) | 136 (14.3) | 846 (17.6) | <0.001 |
| Sleep Disorder | 202 (6.9) | 71 (7.5) | 359 (7.5) | 0.655 |
| Genetic Disorder | 108 (3.7) | 19 (2.0) | 101 (2.1) | <0.001 |
| Delayed Milestone | 772 (26.5) | 181 (19.0) | 1,050 (21.9) | <0.001 |
| Epilepsy | 86 (3.0) | 17 (1.8) | 125 (2.6) | 0.148 |
| OT Feeding Difficulties | 275 (9.4) | 97 (10.2) | 424 (8.8) | 0.345 |
| Intellectual Disability | 28 (1.0) | <10 | 52 (1.1) | 0.279 |
| Other Mental Health | 116 (4.0) | 33 (3.5) | 334 (7.0) | <0.001 |
| PT/OT | 540 (18.5) | 131 (13.8) | 779 (16.2) | 0.001 |
| ENT/Audiology | 142 (4.9) | 44 (4.6) | 306 (6.4) | 0.007 |
| Depression | <10 | <10 | 24 (0.5) | 0.002 |
| Anxiety | 58 (2.0) | 20 (2.1) | 232 (4.8) | <0.001 |
| OCD | 9 (0.3) | <10 | 20 (0.4) | 0.300 |
NOTES: ADHD = attention-deficit/hyperactivity disorder; ENT = ear, nose, and throat; OCD = obsessive-compusive disorder; OT = occupational therapy; PT = physical therapy.
TABLE D-6 Clinical Characteristics among Age 5
| Characteristic | Continuous | Intermittent | Non-participant | p |
|---|---|---|---|---|
| N | 2,355 | 756 | 4,475 | |
| Dietitian | 348 (14.8) | 94 (12.4) | 583 (13.0) | 0.087 |
| Speech | 915 (38.9) | 216 (28.6) | 1,536 (34.3) | <0.001 |
| ADHD | 577 (24.5) | 209 (27.6) | 1,437 (32.1) | <0.001 |
| Sleep Disorder | 169 (7.2) | 41 (5.4) | 329 (7.4) | 0.160 |
| Genetic Disorder | 86 (3.7) | 27 (3.6) | 89 (2.0) | <0.001 |
| Delayed Milestone | 469 (19.9) | 103 (13.6) | 709 (15.8) | <0.001 |
| Epilepsy | 85 (3.6) | 13 (1.7) | 121 (2.7) | 0.014 |
| OT Feeding Difficulties | 170 (7.2) | 43 (5.7) | 276 (6.2) | 0.163 |
| Intellectual Disability | 36 (1.5) | 11 (1.5) | 60 (1.3) | 0.817 |
| Other Mental Health | 133 (5.6) | 47 (6.2) | 369 (8.2) | <0.001 |
| PT/OT | 365 (15.5) | 85 (11.2) | 634 (14.2) | 0.014 |
| ENT/Audiology | 107 (4.5) | 21 (2.8) | 230 (5.1) | 0.016 |
| Depression | <10 | <10 | 29 (0.6) | 0.040 |
| Anxiety | 111 (4.7) | 48 (6.3) | 378 (8.4) | <0.001 |
| OCD | 10 (0.4) | 4 (0.5) | 35 (0.8) | 0.197 |
NOTES: ADHD = attention-deficit/hyperactivity disorder; ENT = ear, nose, and throat; OCD = obsessive-compusive disorder; OT = occupational therapy; PT = physical therapy.
TABLE D-7 Clinical Characteristics among Ages 6–11
| Characteristic | Continuous | Intermittent | Non-participant | p |
|---|---|---|---|---|
| N | 7,862 | 2,875 | 25,797 | |
| Dietitian | 1,002 (12.7) | 295 (10.3) | 2,641 (10.2) | <0.001 |
| Speech | 2,010 (25.6) | 538 (18.7) | 4,171 (16.2) | <0.001 |
| ADHD | 3,449 (43.9) | 1,353 (47.1) | 13,686 (53.1) | <0.001 |
| Sleep Disorder | 709 (9.0) | 225 (7.8) | 1,867 (7.2) | <0.001 |
| Genetic Disorder | 313 (4.0) | 74 (2.6) | 552 (2.1) | <0.001 |
| Delayed Milestone | 967 (12.3) | 209 (7.3) | 1,716 (6.7) | <0.001 |
| Epilepsy | 363 (4.6) | 109 (3.8) | 832 (3.2) | <0.001 |
| OT Feeding Difficulties | 359 (4.6) | 110 (3.8) | 820 (3.2) | <0.001 |
| Intellectual Disability | 271 (3.4) | 73 (2.5) | 570 (2.2) | <0.001 |
| Other Mental Health | 813 (10.3) | 345 (12.0) | 4,353 (16.9) | <0.001 |
| PT/OT | 1,002 (12.7) | 271 (9.4) | 2,241 (8.7) | <0.001 |
| ENT/Audiology | 268 (3.4) | 72 (2.5) | 856 (3.3) | 0.050 |
| Depression | 200 (2.5) | 126 (4.4) | 1,541 (6.0) | <0.001 |
| Anxiety | 1,069 (13.6) | 489 (17.0) | 5,715 (22.2) | <0.001 |
| OCD | 107 (1.4) | 46 (1.6) | 536 (2.1) | <0.001 |
NOTES: ADHD = attention-deficit/hyperactivity disorder; ENT = ear, nose, and throat; OCD = obsessive-compusive disorder; OT = occupational therapy; PT = physical therapy.
TABLE D-8 Clinical Characteristics among Ages 12–18
| Characteristic | Continuous | Intermittent | Non-participant | p |
|---|---|---|---|---|
| N | 2,729 | 1,169 | 26,249 | |
| Dietitian | 275 (10.1) | 100 (8.6) | 1,943 (7.4) | <0.001 |
| Speech | 385 (14.1) | 93 (8.0) | 1,252 (4.8) | <0.001 |
| ADHD | 1,171 (42.9) | 527 (45.1) | 13,129 (50.0) | <0.001 |
| Sleep Disorder | 246 (9.0) | 105 (9.0) | 2,061 (7.9) | 0.047 |
| Genetic Disorder | 126 (4.6) | 34 (2.9) | 508 (1.9) | <0.001 |
| Delayed Milestone | 129 (4.7) | 20 (1.7) | 365 (1.4) | <0.001 |
| Epilepsy | 189 (6.9) | 44 (3.8) | 987 (3.8) | <0.001 |
| OT Feeding Difficulties | 48 (1.8) | 16 (1.4) | 222 (0.8) | <0.001 |
| Intellectual Disability | 197 (7.2) | 51 (4.4) | 992 (3.8) | <0.001 |
| Other Mental Health | 414 (15.2) | 253 (21.6) | 6,683 (25.5) | <0.001 |
| PT/OT | 191 (7.0) | 49 (4.2) | 860 (3.3) | <0.001 |
| ENT/Audiology | 76 (2.8) | 36 (3.1) | 539 (2.1) | 0.004 |
| Depression | 215 (7.9) | 191 (16.3) | 6,687 (25.5) | <0.001 |
| Anxiety | 585 (21.4) | 323 (27.6) | 9,651 (36.8) | <0.001 |
| OCD | 79 (2.9) | 41 (3.5) | 1,130 (4.3) | 0.001 |
NOTES: ADHD = attention-deficit/hyperactivity disorder; ENT = ear, nose, and throat; OCD = obsessive-compusive disorder; OT = occupational therapy; PT = physical therapy.
included overall and communication scores from the SRS. The committee determined that domain specific subscores would more appropriately capture behaviors that ABA could be used to address over the total score of the PDDBI. Although these subscores are important, they were not necessarily used by clinicians to measure behaviors unique to the individual.
The goals of ABA, and the corresponding assessment measures, are not captured in these data and substantial misclassification likely exists.
Descriptive analyses were performed to understand the utility of assessment scores: determined the number of assessments by year and compiled the number of beneficiaries with valid assessments (by number of assessments completed). In doing this, it was revealed that over half of the assessments in the database did not contain a date of assessment but rather included only the year/quarter when the data were ingested into the DHA database, which does not correspond to when the assessment was performed. Westat also identified issues with multiple scores in the same time period or even the same date, but this problem was much smaller than the missing valid dates. Assessments with missing scores were removed when reporting by subscores.
Baseline score was defined as the first recorded assessment for any beneficiary. Preliminary analysis examined the average assessment score and standard deviation by demographic characteristics outlined previously. In this case, demographics (e.g., age) were matched to the nearest date of the assessment, not the first F84.0 code. In addition, Westat also produced a table comparing the scores for first and second assessments for individuals with at least two assessment scores. To determine the impact of the missing dates, Westat performed this analysis among the total beneficiary population with two scores and valid assessment dates and then again among those with two valid dates of assessments.
Associations between ABA intensity and changing score from the PDDBI REXSCA (receptive/expressive social communication abilities dimension) were examined in a sample of 311 autistic individuals using a paired t-test and linear regression. The initial model examined predictors of the baseline PDDBI REXSCA score using linear regression that included age, sex, and ABA intensity groups. This was followed with a paired t-test, testing mean differences between the first and second assessment. Thirdly a linear regression was used with the second assessment as the dependent variable with age, sex, ABA intensity, and the initial assessment score as independent variables. Older age groups and males had a higher first assessment mean REXSCA score. The paired t-test did not detect a difference between mean first and second assessment scores. The older age group (≥10)
had a decreased mean second score; otherwise, there were no associations detected in the final model.
Raw R output from the PDDBI REXSCA model (N = 311)
| ABA hours per week | N | ||
|---|---|---|---|
| 0–5 hour per week | 180 | ||
| >5–10 hours per week | 79 | ||
| >10 hours per week | 52 |
| Age group years | N | ||
|---|---|---|---|
| <5 | 79 | ||
| ≥5 to 10 | 131 | ||
| ≥10 | 101 |
The paired t-test found a −0.69 (95% CI −1.45, 0.07) p = 0.07 change from the first to the second PDDBI REXSCA measurement. This is not significant at an alpha of 0.05.
Multivariable linear regression of intensity, age, and sex on the first REXSCA score.
| B | SE | p-value | |
|---|---|---|---|
| Intercept | 46.2 | 1.9 | <0.001 |
| >5–10 hours | −1.2 | 1.6 | 0.47 |
| >10 hours | −0.9 | 1.9 | 0.62 |
| ≥5 to 10 years old | 4.6 | 1.7 | 0.007 |
| ≥10 years old | 5.5 | 1.9 | 0.003 |
| Males | 3.2 | 1.6 | 0.04 |
Multivariable linear regression of intensity, age, and sex on the second REXSCA score while controlling for the mean centered first REXSCA score.
| B | SE | p-value | |
|---|---|---|---|
| Intercept | 54.8 | 1.1 | <0.001 |
| 1st REXSCA score | 0.9 | 0.03 | <0.001 |
| >5–10 hours | −1.0 | 0.9 | 0.30 |
| >10 hours | −1.2 | 1.1 | 0.30 |
| ≥5 to 10 years old | −1.2 | 1.0 | 0.20 |
| ≥10 years old | −2.3 | 1.1 | 0.03 |
| Males | −0.6 | 0.9 | 0.50 |
The committee also performed a preliminary analysis of 1,495 ACD participants who had received ABA and had been assessed twice by Vineland-3. At baseline, the average Vineland-3 score was 70. The amount of ABA later received was positively associated with the baseline score. Westat also constructed a model to examine changes in Vineland scores over time among these participants controlling for amount of ABA, sex, and age group. Small overall improvements in the sample were observed, with association more pronounced among three-to-six-year-old children. And note that improvement did not vary with amount of ABA (i.e., observe similar levels of improvement across the groups defined by amount of ABA [i.e., 0–5, 5–10, 10–20, and 20 or more hours per week]).
Raw R output from the Vineland ABC model (N = 1,495)
| ABA hours per week | N | ||
|---|---|---|---|
| 0–5 hour per week | 538 | ||
| >5–10 hours per week | 387 | ||
| ≥10–20 hours per week | 412 | ||
| >20 hours per week | 158 |
| Age group years | N | ||
|---|---|---|---|
| <3 | 464 | ||
| ≥3 to 6 | 703 | ||
| ≥6 | 328 |
Multivariable linear regression of intensity, age, and sex on the first Vineland ABC score.
| B | SE | p-value | |
|---|---|---|---|
| Intercept | 66.2 | 0.9 | <0.001 |
| >5–10 hours | −0.8 | 0.8 | 0.28 |
| ≥10–20 hours | −2.7 | 0.8 | <0.001 |
| >20 hours | −4.7 | 1.0 | <0.001 |
| ≥3 to 6 years old | 4.0 | 0.7 | <0.001 |
| ≥6 years old | 6.7 | 0.8 | <0.001 |
| Males | −0.2 | 0.7 | 0.80 |
Multivariable linear regression of intensity, age, and sex on the second Vineland ABC score while controlling for the mean centered first Vineland ABC score.
| B | SE | p-value | |
|---|---|---|---|
| Intercept | 72.8 | 0.7 | <0.001 |
| 1st Vine ABC score | 0.7 | 0.0 | <0.001 |
| >5–10 hours | 0.3 | 0.6 | 0.60 |
| ≥10–20 hours | −0.7 | 0.6 | 0.28 |
| >20 hours | 0.6 | 0.9 | 0.50 |
| ≥3 to 6 years old | −1.4 | 0.6 | 0.01 |
| ≥6 years old | −0.2 | 0.7 | 0.70 |
| Males | −0.2 | 0.6 | 0.70 |
EHR systems do not collect data with research-based objectives in mind and can be incontinuous across data fields that would inform specific research questions. Variables may have high levels of missingness. For example, the DHA has communicated that large proportions of race/ethnicity data are missing. There are additional challenges stemming from omissions common in administrative data beyond inconsistencies and missingness. Claims-based data will not capture information beyond what is needed for a billable claim, despite its relevancy for research questions.
The ability to capture breaks in care, and their cause, can be challenging in claims-based data sources. Breaks in care can be uniquely detrimental to individuals with autism as autistic individuals benefit from consistency and routine. This is exacerbated in this study because military families experience frequent breaks in care due to PCS relocations, which happen every two to three years. It is difficult to ascertain when care was stopped due to a factor that may be captured by administrative data, such as referral exhaustion, or a reason not included such as choosing to not participate in ABA. ABA is intended to be a continuous treatment with the same provider or set of providers so changes to ABA providers, and delays associated with those changes, could impact outcomes.
Claims records will have important historical components omitted as well. The time that ICD codes were recorded may not, in and of itself, identify when the condition was originally recognized. For example, an individual could join TRICARE after an autism diagnosis was recognized in a different healthcare system. The age of an individual at diagnosis has been suggested by the committee as a marker of autism severity. And in turn autism severity could be a strong predictor of service utilization.
Claims-based data omissions can lead to biases if comparisons are made between populations with important unmeasured factors. This study is not a randomized control study, making careful development of an
appropriate comparison group important if comparisons of ABA-influenced outcomes are to be made. Control, or comparison, individuals who do not participate could choose to do so for reasons that are not captured in claims, and those reasons could be important to any outcome examined, which would lead to uncorrectable biases.
Westat used secure file transfer and storage processes for data containing de-identified personal and health information in compliance with federal and DoD policies. All data containing health information were encrypted and securely transferred between DHA and Westat using a Health Insurance Portability and Accountability Act-compliant cloud server or data transfer platform that is Federal Risk and Authorization Management Program-certified. Westat immediately transferred data to a protected project-specific location on Westat’s file servers. Based on requirements for end-of-project data disposition, Westat will destroy all protected data files and provide a written certification of destruction. The committee will not have access to the protected data provided by DoD and will rely on Westat’s analytic summaries for its deliberations and report.
This page intentionally left blank.